glp 1 aging Beyond GLP‐1s: The blueprint for systemic therapeutics that will reshape and medicine - Kern - 2025 - British Journal of Clinical Pharmacology GLP-1 receptor agonism counteracts omics

Obesity-related metabolic disturbances, including metabolic syndrome, insulin resistance, and chronic low-grade inflammation, further contribute to OSAS pathogenesis

Natural fibres such as wool and thermal base layers can be particularly helpful

5,6 In addition, receptor activator of nuclear factor kappa beta ligand (RANKL), that plays a crucial role in osteoclast activity and bone resorption, 21 also directly influences pancreatic beta-cell function and overall metabolism, with its activity being compromised in obesity and T2D

Clinicians who broaden their diagnostic criteria and consider GLP1s within a liverfirst strategy may improve outcomes for patients who would otherwise go untreated or underdiagnosed

Your diabetes management plan should be discussed with your GP or diabetes specialist well in advance of surgery